Time filter

Source Type

Limbe, Cameroon

Pomajbikova K.,University of Veterinary And Pharmaceutical Sciences Brno | Obornik M.,Academy of Sciences of the Czech Republic | Obornik M.,University of South Bohemia | Horak A.,Academy of Sciences of the Czech Republic | And 11 more authors.
PLoS Neglected Tropical Diseases | Year: 2013

Balantidiasis is considered a neglected zoonotic disease with pigs serving as reservoir hosts. However, Balantidium coli has been recorded in many other mammalian species, including primates. Here, we evaluated the genetic diversity of B. coli in non-human primates using two gene markers (SSrDNA and ITS1-5.8SDNA-ITS2). We analyzed 49 isolates of ciliates from fecal samples originating from 11 species of captive and wild primates, domestic pigs and wild boar. The phylogenetic trees were computed using Bayesian inference and Maximum likelihood. Balantidium entozoon from edible frog and Buxtonella sulcata from cattle were included in the analyses as the closest relatives of B. coli, as well as reference sequences of vestibuliferids. The SSrDNA tree showed the same phylogenetic diversification of B. coli at genus level as the tree constructed based on the ITS region. Based on the polymorphism of SSrDNA sequences, the type species of the genus, namely B. entozoon, appeared to be phylogenetically distinct from B. coli. Thus, we propose a new genus Neobalantidium for the homeothermic clade. Moreover, several isolates from both captive and wild primates (excluding great apes) clustered with B. sulcata with high support, suggesting the existence of a new species within this genus. The cysts of Buxtonella and Neobalantidium are morphologically indistinguishable and the presence of Buxtonella-like ciliates in primates opens the question about possible occurrence of these pathogens in humans. © 2013 Pomajbíková et al.

Harvala H.,Royal Infirmary | Harvala H.,University of Edinburgh | McIntyre C.L.,University of Edinburgh | Imai N.,University of Edinburgh | And 18 more authors.
Emerging Infectious Diseases | Year: 2012

To estimate population exposure of apes and Old World monkeys in Africa to enteroviruses (EVs), we conducted a seroepidemiologic study of serotype-specific neutralizing antibodies against 3 EV types. Detection of species A, B, and D EVs infecting wild chimpanzees demonstrates their potential widespread circulation in primates.

Lankester F.,Limbe Wildlife Center | Kiyang J.A.,Limbe Wildlife Center | Bailey W.,Clinical Parasitology Laboratory | Unwin S.,Chester Zoo
Journal of Zoo and Wildlife Medicine | Year: 2010

A 7-yr-old female western lowland gorilla (Gorilla gorilla gorilla) shared an enclosure with 10 other gorillas at the Limbe Wildlife Centre (LWC), a wildlife rehabilitation centre in Cameroon. The gorilla had been living at the LWC for more than 6 yr prior to the exhibition of irritable bowel syndrome (IBS)-like clinical signs. The gorilla improved dramatically after metronidazole therapy. The report suggests that metronidazole was effective because it eliminated the protozoa, Dientamoeba fragilis. Dientamoeba fragilis should be considered on the differential diagnosis list of any captive gorilla with IBS-like symptoms. © 2010 American Association of Zoo Veterinarians.

Sharp C.P.,University of Edinburgh | LeBreton M.,Global Viral Forecasting | Kantola K.,University of Helsinki | Nana A.,Global Viral Forecasting | And 15 more authors.
Journal of Virology | Year: 2010

Infections with human parvoviruses B19 and recently discovered human bocaviruses (HBoVs) are widespread, while PARV4 infections are transmitted parenterally and prevalent specifically in injecting drug users and hemophiliacs. To investigate the exposure and circulation of parvoviruses related to B19 virus, PARV4, and HBoV in nonhuman primates, plasma samples collected from 73 Cameroonian wild-caught chimpanzees and gorillas and 91 Old World monkey (OWM) species were screened for antibodies to recombinant B19 virus, PARV4, and HBoV VP2 antigens by enzyme-linked immunosorbent assay (ELISA). Moderate to high frequencies of seroreactivity to PARV4 (63% and 18% in chimpanzees and gorillas, respectively), HBoV (73% and 36%), and B19 virus (8% and 27%) were recorded for apes, while OWMs were uniformly negative (for PARV4 and B19 virus) or infrequently reactive (3% for HBoV). For genetic characterization, plasma samples and 54 fecal samples from chimpanzees and gorillas collected from Cameroonian forest floors were screened by PCR with primers conserved within Erythrovirus, Bocavirus, and PARV4 genera. Two plasma samples (chimpanzee and baboon) were positive for PARV4, while four fecal samples were positive for HBoV-like viruses. The chimpanzee PARV4 variant showed 18% and 15% nucleotide sequence divergence in NS and VP1/2, respectively, from human variants (9% and 7% amino acid, respectively), while the baboon variant was substantially more divergent, mirroring host phylogeny. Ape HBoV variants showed complex sequence relationships with human viruses, comprising separate divergent homologues of HBoV1 and the recombinant HBoV3 species in chimpanzees and a novel recombinant species in gorillas. This study provides the first evidence for widespread circulation of parvoviruses in primates and enables future investigations of their epidemiology, host specificity, and (co)evolutionary histories. Copyright © 2010, American Society for Microbiology. All Rights Reserved.

LeBreton M.,Tech Data | LeBreton M.,Metabiota | Djoko C.F.,Global Viral Cameroon | Gillis A.,Global Viral Cameroon | And 12 more authors.
Emerging Microbes and Infections | Year: 2014

Of the seven known species of human retroviruses only one, human T-cell lymphotropic virus type 4 (HTLV-4), lacks a known animal reservoir. We report the largest screening for simian T-cell lymphotropic virus (STLV-4) to date in a wide range of captive and wild non-human primate (NHP) species from Cameroon. Among the 681 wild and 426 captive NHPs examined, we detected STLV-4 infection only among gorillas by using HTLV-4-specific quantitative polymerase chain reaction. The large number of samples analyzed, the diversity of NHP species examined, the geographic distribution of infected animals relative to the known HTLV-4 case, as well as detailed phylogenetic analyses on partial and full genomes, indicate that STLV-4 is endemic to gorillas, and that rather than being an ancient virus among humans, HTLV-4 emerged from a gorilla reservoir, likely through the hunting and butchering of wild gorillas. Our findings shed further light on the importance of gorillas as keystone reservoirs for the evolution and emergence of human infectious diseases and provide a clear course for preventing HTLV-4 emergence through management of human contact with wild gorillas, the development of improved assays for HTLV-4/STLV-4 detection and the ongoing monitoring of STLV-4 among gorillas and for HTLV-4 zoonosis among individuals exposed to gorilla populations. © 2014 SSCC.

Discover hidden collaborations